Location History:
- Shenzhen, CN (2018)
- Nanjing, CN (2016 - 2022)
- Jiangsu, CN (2023)
Company Filing History:
5 out of 15 
4 out of 27,246 
1 out of 4,849 
Years Active: 2016-2023
Title: Innovations of Yafeng Zhang: Pioneering Single-Domain Antibodies
Introduction: Yafeng Zhang, an accomplished inventor based in Nanjing, China, has made significant contributions to the field of biotechnology, particularly in the development of single-domain antibodies. With a total of nine patents to his name, Zhang's work has been influential in advancing therapeutic strategies targeting key proteins involved in immune regulation.
Latest Patents: Among Yafeng Zhang's latest inventions are groundbreaking patents focusing on single-domain antibodies against PD-1 and PD-L1. The patent titled "Single-domain antibodies and variants thereof against PD-1" presents constructs that include a single-domain antibody moiety capable of specifically recognizing the PD-1 protein. Additionally, a separate patent, "Single-domain antibodies and variants thereof against PD-L1," provides constructs that similarly target PD-L1, detailing methods for both production and application of these innovative antibodies. These patents represent significant strides in immune-oncology, providing potential therapeutic avenues for cancer treatment.
Career Highlights: Throughout his career, Yafeng Zhang has been associated with prominent companies in the biotech sector, including Nanjing Legend Biotech Co., Ltd. and Huawei Technologies Co., Limited. His work in these organizations has been pivotal in bridging the gap between research and practical applications in biotechnology, especially in the realm of antibody development.
Collaborations: Zhang has had the opportunity to collaborate with esteemed colleagues, including Chuan-Chu Chou and Shu Wu. These collaborations have further enriched his research, leading to innovative discoveries and advancements in the field of single-domain antibodies.
Conclusion: Yafeng Zhang's contributions to the field of biotechnology through his patents and collaborations showcase his role as a leading inventor in developing therapeutic solutions. His work targeting PD-1 and PD-L1 represents a critical leap forward in cancer therapy. As he continues to innovate, the impact of his inventions will undoubtedly resonate within the scientific community and beyond.